Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
批准号:
10363406
负责人:
Namasivayam Ambalavanan
金额:
$148.56万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-12-15 至 2026-11-30
关键词:
AgeAge-MonthsAsthmaBreathingBronchopulmonary DysplasiaCaffeineCharacteristicsChildChild CareChildhoodClinicalClinical DataClinical TreatmentCognitiveCollaborationsConsentDataDevelopmentDiagnosisDiscipline of NursingDiseaseEarly DiagnosisEarly InterventionEarly identificationEmotionalEnrollmentEventFrequenciesFundingFutureGoalsHealthHypoxemiaImpairmentInfantInfrastructureInterventionIntervention TrialInvestigationKnowledgeLifeLinkMeasuresMotorNational Heart, Lung, and Blood InstituteNeonatalNeonatal Intensive CareNeonatal Intensive Care UnitsNervous System PhysiologyNeurodevelopmental ImpairmentNursery SchoolsOutcomeOxygenPathologicPathway interactionsPatientsPatternPersonsPharmaceutical PreparationsPhysiologicalPlayPopulationPregnancyPremature BirthPremature InfantPrevalencePrevention strategyPreventivePrognosisProspective StudiesProtocols documentationRecordsResearchResearch PersonnelResolutionResourcesRespiratory physiologyRiskRoleSensorySleepSleep Apnea SyndromesStructureTherapeuticTimeTrainingUnited States National Institutes of HealthVentWeaningWorkadvanced analyticsairway hyperresponsivenessasthma modelbaseclinical careclinical phenotypecohortcostearly screeningempoweredexperienceimprovedinfancyinnovationnegative affectneonatal carenovel therapeuticspeerpostnatalprematureprognosticprognostic modelprogramsrehabilitation servicerespiratoryresponsestandard of caresupplemental oxygentargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
This is the application from collaborators of the Prematurity-Related Ventilatory Control (Pre-Vent): Role in
Respiratory Outcomes NHLBI Collaborative Program. Central to this proposal is a prospective study entitled
“Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent
Hypoxemia in Preterm Infants at Pre-school Age”. This multicenter proposal innovatively combines detailed
clinical phenotyping with advanced analytics of longitudinal recordings of intermittent hypoxemia (IH) events to
develop personalized prognostic models of long-term outcomes that could transform clinical care by allowing for
timely identification of at-risk infants and specific pathologic IH patterns for future trials of targeted intervention.
Extremely premature birth and various postnatal factors can negatively affect outcome. In a significant proportion
of extremely premature infants the sequelae persist beyond infancy with relatively high rates of asthma and sleep
disordered breathing (SDB) in childhood and worrisome prevalence of neurodevelopmental impairment (NDI).
This multicenter proposal will systematically and innovatively examine the interaction between IH during neonatal
intensive care and these sequelae by means of detailed clinical phenotyping and advanced analytics. The
proposed investigation will provide personalized prognosis and identification of infants at risk of poor long-term
outcome that could transform clinical care and uncover targets for preventive or therapeutic strategies.
The main goal of this proposal is to build prognostic models of asthma, SDB, and NDI at pre-school age in former
extremely premature infants based on physiologic waveforms and clinical characteristics in the neonatal
intensive care unit. To achieve this goal this time-sensitive proposal leverages the population, research structure
and expertise, and analytic resources developed for the NHLBI-funded Pre-Vent collaboration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Let-7b in BPD
-
批准号:10655734
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
-
批准号:10576754
-
项目类别:
-
资助金额:$50.02万
-
财政年份:2023
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10493363
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10891299
-
项目类别:
-
资助金额:$22.15万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
UAB Clinical Site HEAL Neonatal Opioid Withdrawal Pharmacological Treatments
-
批准号:10372486
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
-
批准号:10541156
-
项目类别:
-
资助金额:$152.13万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Vital Signs In Opioid-Exposed Neonates
-
批准号:10360908
-
项目类别:
-
资助金额:$51.99万
-
财政年份:2021
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Acute Renal Injury Sequelae in NICU Graduates (ARISING)
-
批准号:9899244
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2019
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:10006023
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:9762173
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Pre-Vent Apnea
-
批准号:9168075
-
项目类别:
-
资助金额:$19.53万
-
财政年份:2016
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9292368
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:9143795
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
STOP BPD
-
批准号:8996355
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2015
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:9062496
-
项目类别:
-
资助金额:$73.48万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8685690
-
项目类别:
-
资助金额:$74.01万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Alveolar DevMAP
-
批准号:8870421
-
项目类别:
-
资助金额:$73.5万
-
财政年份:2014
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8240026
-
项目类别:
-
资助金额:$59.75万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8610334
-
项目类别:
-
资助金额:$57.19万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位:
Azithromycin to prevent BPD in ureaplasma-infected preterms.
-
批准号:8015539
-
项目类别:
-
资助金额:$62.29万
-
财政年份:2011
-
负责人:Namasivayam Ambalavanan
-
依托单位: